Sangamo Therapeutics

$10.98
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.23 (-2.04%) Today
-$0.04 (-0.36%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SGMO and other stocks, options, and ETFs commission-free!

About SGMO

Sangamo Therapeutics, Inc. Common Stock, also called Sangamo Therapeutics, is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins.

CEO
Alexander D. Macrae
Employees
413
Headquarters
Brisbane, California
Founded
1995
Market Cap
1.67B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.14M
High Today
$11.25
Low Today
$10.83
Open Price
$11.25
Volume
894.23K
52 Week High
$19.43
52 Week Low
$6.97

SGMO Earnings

-$0.37
-$0.23
-$0.10
$0.04
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

BBQ
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure